These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30088263)

  • 21. Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.
    Li DJ; Xiao D
    BMC Cancer; 2017 Jul; 17(1):501. PubMed ID: 28743242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XRCC1 - Strategies for coordinating and assembling a versatile DNA damage response.
    London RE
    DNA Repair (Amst); 2020 Sep; 93():102917. PubMed ID: 33087283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transcription-coupled DNA repair-initiating protein CSB promotes XRCC1 recruitment to oxidative DNA damage.
    Menoni H; Wienholz F; Theil AF; Janssens RC; Lans H; Campalans A; Radicella JP; Marteijn JA; Vermeulen W
    Nucleic Acids Res; 2018 Sep; 46(15):7747-7756. PubMed ID: 29955842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
    Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
    J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
    Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
    Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk.
    Yuan T; Wei J; Luo J; Liu M; Deng S; Chen P
    Dig Dis Sci; 2012 Sep; 57(9):2451-7. PubMed ID: 22565339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.
    Cai L; You NC; Lu H; Mu LN; Lu QY; Yu SZ; Le AD; Marshall J; Heber D; Zhang ZF
    Cancer; 2006 Jun; 106(11):2345-54. PubMed ID: 16639733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.
    Li K; Guo W; Li Z; Wang Y; Sun B; Xu D; Ling J; Song H; Liao Y; Wang T; Jing B; Hu M; Kuang Y; Wang Q; Yao F; Sun A; Zhu L; Wang L; Deng J
    Neoplasia; 2019 Jun; 21(6):602-614. PubMed ID: 31071657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
    Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W
    Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-671-5p Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma through Targeting ALDH2.
    Chen X; Luo J; Gao S; Jiang J; Yang B; Zhang Z
    Crit Rev Eukaryot Gene Expr; 2022; 32(4):73-82. PubMed ID: 35695667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1.
    Mani RS; Mermershtain I; Abdou I; Fanta M; Hendzel MJ; Glover JNM; Weinfeld M
    J Biol Chem; 2019 Jan; 294(2):520-530. PubMed ID: 30446622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies.
    Matsumoto A; Nakashima C; Kimura S; Sueoka E; Aragane N
    BMC Cancer; 2021 May; 21(1):584. PubMed ID: 34022841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair.
    Adamowicz M; Hailstone R; Demin AA; Komulainen E; Hanzlikova H; Brazina J; Gautam A; Wells SE; Caldecott KW
    Nat Cell Biol; 2021 Dec; 23(12):1287-1298. PubMed ID: 34811483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers.
    Wong RH; Wang JD; Hsieh LL; Cheng TJ
    Arch Toxicol; 2003 Aug; 77(8):433-40. PubMed ID: 12739102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction Between Environmental Risk Factors and Catechol-O-Methyltransferase (COMT) and X-Ray Repair Cross-Complementing Protein 1 (XRCC1) Gene Polymorphisms in Risk of Lung Cancer Among Non-Smoking Chinese Women: A Case-Control Study.
    Pan JL; Gao J; Hou JH; Hu DZ; Li L
    Med Sci Monit; 2018 Aug; 24():5689-5697. PubMed ID: 30109864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Activation Of Aldehyde Dehydrogenase 2 Protects Against Heatstroke-Induced Acute Lung Injury by Modulating Oxidative Stress and Endothelial Dysfunction.
    Tsai HY; Hsu YJ; Lu CY; Tsai MC; Hung WC; Chen PC; Wang JC; Hsu LA; Yeh YH; Chu P; Tsai SH
    Front Immunol; 2021; 12():740562. PubMed ID: 34764958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response.
    Reber JM; Božić-Petković J; Lippmann M; Mazzardo M; Dilger A; Warmers R; Bürkle A; Mangerich A
    Cell Biol Toxicol; 2023 Feb; 39(1):345-364. PubMed ID: 35778544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Xu C; Li Y; Pan J; Wang S; Ye Z; Cai X; Zheng H; Yin Z; Cao Z
    Discov Med; 2024 Jan; 36(180):82-90. PubMed ID: 38273748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway.
    Xia P; Liu DH; Wang D; Wen GM; Zhao ZY
    Free Radic Biol Med; 2023 Sep; 206():125-133. PubMed ID: 37406742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.